NEOSTIGMINE METHYLSULFATE INJECTION USP
MARCAN PHARMACEUTICALS INC
Quick answers
Is there a shortage of NEOSTIGMINE METHYLSULFATE INJECTION USP in Canada?
No. There is no current shortage of NEOSTIGMINE METHYLSULFATE INJECTION USP 1MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
NEOSTIGMINE METHYLSULFATE INJECTION USP
SANDOZ CANADA INCORPORATED
PROSTIGMIN INJ 1:1000 USP
ICN CANADA LTD.
NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP
DAVID BULL LABORATORIES (PTY) LTD.
PMS-NEOSTIGMINE METHYLSULFATE INJ 1MG/ML
PHARMASCIENCE INC
NEOSTIGMINE OMEGA
OMEGA LABORATORIES LIMITED
NEOSTIGMINE METHYLSULFATE INJECTION
FRESENIUS KABI CANADA LTD
DIN
02475499
Strength
1MG
Dosage Form
Solution
Route
Subcutaneous Intramuscular Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MARCAN PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02537893
500MG · DIN 02481073
1MG · DIN 02554364
100MG · DIN 02555093
100MG · DIN 00297763
3.5MG · DIN 02493306
150MG · DIN 02546639
1000MG · DIN 02560216
2000MG · DIN 02560224
10MG · DIN 02480530
1MG · DIN 02502623
0.2MG · DIN 02502615